Mira A Patel
Overview
Explore the profile of Mira A Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cha E, Patel M, Zhang Y, Lobaugh S, Zhang Z, McCormick B, et al.
Adv Radiat Oncol
. 2022 Dec;
8(1):101113.
PMID: 36483067
Purpose: : Guidelines for early-stage breast cancer allow for radiation therapy (RT) omission after breast conserving surgery among older women, though high utilization of RT persists. This study explored surgeon...
2.
Ostendorf B, Patel M, Bilanovic J, Hoffmann H, Carrasco S, Rice C, et al.
Nature
. 2022 Sep;
611(7935):346-351.
PMID: 36130725
Clinical outcomes of severe acute respiratory syndrome 2 (SARS-CoV-2) infection are highly heterogeneous, ranging from asymptomatic infection to lethal coronavirus disease 2019 (COVID-19). The factors underlying this heterogeneity remain insufficiently...
3.
Patel M, Tavazoie S
Immunity
. 2022 Apr;
55(4):580-582.
PMID: 35417670
Interferon signaling mediates resistance to immune checkpoint blockade therapy, but the underlying mechanisms are poorly understood. In this issue of Immunity, Cucolo et al. identify RIPK1 as an interferon-stimulated gene...
4.
Patel M, Kollmeier M, McBride S, Gorovets D, Varghese M, Chan L, et al.
Radiother Oncol
. 2019 Jun;
140:34-40.
PMID: 31177042
Background And Purpose: To identify early biochemical predictors of survival in intermediate- and high-risk prostate cancer patients with a pre-treatment PSA <20 ng/mL following definitive radiation therapy (RT) and androgen...
5.
Patel M, Marciscano A, Hu C, Jusue-Torres I, Garg R, Rashid A, et al.
Front Oncol
. 2017 Sep;
7:200.
PMID: 28929084
Purpose: The aim of this study is to evaluate long-term treatment outcome and toxicities among vestibular schwannoma (VS) patients treated with hypofractionated stereotactic radiotherapy (HSRT). Methods: 383 patients with unilateral...
6.
Yasar S, Jusue-Torres I, Lu J, Robison J, Patel M, Crain B, et al.
PLoS One
. 2017 Aug;
12(8):e0182288.
PMID: 28786990
We aimed to determine whether presence of AD neuropathology predicted cognitive, gait and balance measures in patients with idiopathic normal pressure hydrocephalus (iNPH) after shunt surgery. This is a prospective...
7.
Patel M, Eytan D, Bishop J, Califano J
Otolaryngol Head Neck Surg
. 2016 Dec;
156(2):329-333.
PMID: 27899468
Objective To determine the impact of unilateral vagal sacrifice for vagal schwannoma on postoperative swallowing function. Study Design Case series, chart review. Setting Academic medical institution. Subjects and Methods Ten...
8.
Patel M, Kim J, Theodros D, Tam A, Velarde E, Kochel C, et al.
J Immunother Cancer
. 2016 Nov;
4:74.
PMID: 27822377
[This corrects the article DOI: 10.1186/s40425-016-0132-2.].
9.
Patel M, Mener D, Garcia-Esquinas E, Navas-Acien A, Agrawal Y, Lin S
PLoS One
. 2016 Oct;
11(10):e0163926.
PMID: 27711178
Objectives: To describe the association between active, environmental tobacco smoke (ETS) exposure and the prevalence of eustachian tube dysfunction (ETD) in the U.S. pediatric population. Study Design: Cross-sectional. Setting: U.S....
10.
Kim J, Patel M, Mangraviti A, Kim E, Theodros D, Velarde E, et al.
Clin Cancer Res
. 2016 Jul;
23(1):124-136.
PMID: 27358487
Purpose: Checkpoint molecules like programmed death-1 (PD-1) and T-cell immunoglobulin mucin-3 (TIM-3) are negative immune regulators that may be upregulated in the setting of glioblastoma multiforme. Combined PD-1 blockade and...